{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T03:36:04Z","timestamp":1785036964938,"version":"3.55.0"},"reference-count":192,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41584-025-01333-7","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:50:15Z","timestamp":1765198215000},"page":"118-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Emerging and underrecognized viral triggers of autoimmune inflammatory rheumatic disease flares"],"prefix":"10.1038","volume":"22","author":[{"given":"Ivonne","family":"Melano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elaine","family":"Husni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas S.","family":"Piuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8174-0893","authenticated-orcid":false,"given":"Suan-Sin","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8840-1823","authenticated-orcid":false,"given":"Weiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"1333_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1337406","volume":"15","author":"CO Hileman","year":"2024","unstructured":"Hileman, C. O., Malakooti, S. K., Patil, N., Singer, N. G. & McComsey, G. A. New-onset autoimmune disease after COVID-19. Front. Immunol. 15, 1337406 (2024).","journal-title":"Front. Immunol."},{"key":"1333_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.trsl.2024.12.004","volume":"276","author":"A Korzeniowska","year":"2025","unstructured":"Korzeniowska, A. & Bryl, E. Infectious agents in the pathogenesis of autoimmune rheumatic diseases. Transl. Res. 276, 39\u201345 (2025).","journal-title":"Transl. Res."},{"key":"1333_CR3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/v15030782","volume":"15","author":"B Sundaresan","year":"2023","unstructured":"Sundaresan, B., Shirafkan, F., Ripperger, K. & Rattay, K. The role of viral infections in the onset of autoimmune diseases. Viruses 15, 782 (2023).","journal-title":"Viruses"},{"key":"1333_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-001131","volume":"11","author":"F El Hadiyen","year":"2024","unstructured":"El Hadiyen, F., Tsang, A. S. M. W. P., Lissenberg-Witte, B. I., Voskuyl, A. E. & Bultink, I. E. M. Intercurrent infection as a risk factor for disease flares in patients with systemic lupus erythematosus. Lupus Sci. Med. 11, e001131 (2024).","journal-title":"Lupus Sci. Med."},{"key":"1333_CR5","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3390\/pathogens13110934","volume":"13","author":"GA Ramirez","year":"2024","unstructured":"Ramirez, G. A. et al. Infection-associated flares in systemic lupus erythematosus. Pathogens 13, 934 (2024).","journal-title":"Pathogens"},{"key":"1333_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52748-3","volume":"14","author":"R Li","year":"2024","unstructured":"Li, R. et al. Analysis of related factors for RA flares after SARS-CoV-2 infection: a retrospective study from patient survey. Sci. Rep. 14, 4243 (2024).","journal-title":"Sci. Rep."},{"key":"1333_CR7","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1093\/rheumatology\/kead601","volume":"63","author":"CC Mok","year":"2024","unstructured":"Mok, C. C., Cheung, C. C. L., Chan, K. L., Tse, S. M. & To, C. H. Effect of SARS-CoV2 infection on disease flares in patients with systemic lupus erythematosus: a case-control study. Rheumatology 63, 3390\u20133396 (2024).","journal-title":"Rheumatology"},{"key":"1333_CR8","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/j.ijid.2010.09.008","volume":"15","author":"G Garc\u00eda","year":"2011","unstructured":"Garc\u00eda, G. et al. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int. J. Infect. Dis. 15, e38\u2013e43 (2011).","journal-title":"Int. J. Infect. Dis."},{"key":"1333_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20185-8","volume":"8","author":"T Koma","year":"2018","unstructured":"Koma, T. et al. Zika virus infection elicits auto-antibodies to C1q. Sci. Rep. 8, 1882 (2018).","journal-title":"Sci. Rep."},{"key":"1333_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"1333_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53356-5","volume":"15","author":"AF Jernbom","year":"2024","unstructured":"Jernbom, A. F. et al. Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19. Nat. Commun. 15, 8941 (2024).","journal-title":"Nat. Commun."},{"key":"1333_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00402-22","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. Viral mimicry of interleukin-17A by SARS-CoV-2 ORF8. mBio 13, e0040222 (2022).","journal-title":"mBio"},{"key":"1333_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.178820","volume":"9","author":"I Melano","year":"2024","unstructured":"Melano, I. et al. SARS-CoV-2 ORF8 drives osteoclastogenesis in preexisting immune-mediated inflammatory diseases. JCI Insight 9, e178820 (2024).","journal-title":"JCI Insight"},{"key":"1333_CR14","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1038\/s41590-023-01661-4","volume":"24","author":"N Huot","year":"2023","unstructured":"Huot, N. et al. SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-\u03b3 and NK cells. Nat. Immunol. 24, 2068\u20132079 (2023).","journal-title":"Nat. Immunol."},{"key":"1333_CR15","doi-asserted-by":"publisher","first-page":"589380","DOI":"10.3389\/fimmu.2020.589380","volume":"11","author":"B Kalfaoglu","year":"2020","unstructured":"Kalfaoglu, B., Almeida-Santos, J., Tye, C. A., Satou, Y. & Ono, M. T-cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis. Front. Immunol. 11, 589380 (2020).","journal-title":"Front. Immunol."},{"key":"1333_CR16","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.14336\/AD.2021.0709","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. Regulatory T cells in COVID-19. Aging Dis. 12, 1545\u20131553 (2021).","journal-title":"Aging Dis."},{"key":"1333_CR17","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154069","volume":"23","author":"VI Shubayev","year":"2022","unstructured":"Shubayev, V. I., Dolkas, J., Catroli, G. F. & Chernov, A. V. A human coronavirus OC43-derived polypeptide causes neuropathic pain. EMBO Rep. 23, e54069 (2022).","journal-title":"EMBO Rep."},{"key":"1333_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020457","volume":"6","author":"C Terao","year":"2011","unstructured":"Terao, C. et al. Myelin basic protein as a novel genetic risk factor in rheumatoid arthritis-a genome-wide study combined with immunological analyses. PLoS ONE 6, e20457 (2011).","journal-title":"PLoS ONE"},{"key":"1333_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf6598","volume":"15","author":"JD Herman","year":"2023","unstructured":"Herman, J. D. et al. Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases. Sci. Transl. Med. 15, eadf6598 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1333_CR20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/1096-9071(20000201)63:2<143::AID-JMV1009>3.0.CO;2-L","volume":"63","author":"C-F Lin","year":"2001","unstructured":"Lin, C.-F. et al. Generation of IgM anti-platelet autoantibody in dengue patients. J. Med. Virol. 63, 143\u2013149 (2001).","journal-title":"J. Med. Virol."},{"key":"1333_CR21","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.4049\/jimmunol.0900255","volume":"184","author":"J-J Hoarau","year":"2010","unstructured":"Hoarau, J.-J. et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J. Immunol. 184, 5914\u20135927 (2010).","journal-title":"J. Immunol."},{"key":"1333_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004261","volume":"4","author":"LFP Ng","year":"2009","unstructured":"Ng, L. F. P. et al. IL-1\u03b2, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS ONE 4, e4261 (2009).","journal-title":"PLoS ONE"},{"key":"1333_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005238","volume":"11","author":"V Reddy","year":"2017","unstructured":"Reddy, V., Desai, A., Krishna, S. S. & Vasanthapuram, R. Molecular mimicry between Chikungunya virus and host components: a possible mechanism for the arthritic manifestations. PLOS Negl. Trop. Dis. 11, e0005238 (2017).","journal-title":"PLOS Negl. Trop. Dis."},{"key":"1333_CR24","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/rheumatology\/kei023","volume":"44","author":"X Chang","year":"2005","unstructured":"Chang, X. et al. Citrullination of fibronectin in rheumatoid arthritis synovial tissue. Rheumatology 44, 1374\u20131382 (2005).","journal-title":"Rheumatology"},{"key":"1333_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.molimm.2011.07.021","volume":"49","author":"P Li","year":"2011","unstructured":"Li, P. et al. Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation. Mol. Immunol. 49, 64\u201374 (2011).","journal-title":"Mol. Immunol."},{"key":"1333_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","volume":"171","author":"MM Markiewski","year":"2007","unstructured":"Markiewski, M. M. & Lambris, J. D. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 171, 715\u2013727 (2007).","journal-title":"Am. J. Pathol."},{"key":"1333_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/2040622320965067","volume":"11","author":"I Arias de la Rosa","year":"2020","unstructured":"Arias de la Rosa, I. et al. Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis. Ther. Adv. Chronic Dis. 11, 2040622320965067 (2020).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"1333_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55730-6","volume":"10","author":"SSK Venigalla","year":"2020","unstructured":"Venigalla, S. S. K., Premakumar, S. & Janakiraman, V. A possible role for autoimmunity through molecular mimicry in alphavirus mediated arthritis. Sci. Rep. 10, 938 (2020).","journal-title":"Sci. Rep."},{"key":"1333_CR29","doi-asserted-by":"publisher","first-page":"e00289","DOI":"10.1128\/mbio.00289-22","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Interleukin-17 contributes to chikungunya virus-induced disease. mBio 13, e00289\u201300222 (2022).","journal-title":"mBio"},{"key":"1333_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010185","volume":"18","author":"H Mostafavi","year":"2022","unstructured":"Mostafavi, H. et al. Interleukin-17 contributes to Ross River virus-induced arthritis and myositis. PLoS Pathog. 18, e1010185 (2022).","journal-title":"PLoS Pathog."},{"key":"1333_CR31","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jbspin.2006.11.019","volume":"74","author":"N Colin de Verdi\u00e8re","year":"2007","unstructured":"Colin de Verdi\u00e8re, N. & Molina, J.-M. Rheumatic manifestations caused by tropical viruses. Jt Bone Spine 74, 410\u2013413 (2007).","journal-title":"Jt Bone Spine"},{"key":"1333_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1006\/viro.2002.1587","volume":"301","author":"SJR Way","year":"2002","unstructured":"Way, S. J. R., Lidbury, B. A. & Banyer, J. L. Persistent Ross River virus infection of murine macrophages: an in vitro model for the study of viral relapse and immune modulation during long-term infection. Virology 301, 281\u2013292 (2002).","journal-title":"Virology"},{"key":"1333_CR33","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1097\/01.bor.0000130537.76808.26","volume":"16","author":"A Suhrbier","year":"2004","unstructured":"Suhrbier, A. & La Linn, M. Clinical and pathologic aspects of arthritis due to ross river virus and other alphaviruses. Curr. Opin. Rheumatol. 16, 374\u2013379 (2004).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1333_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1099\/0022-1317-77-3-407","volume":"77","author":"ML Linn","year":"1996","unstructured":"Linn, M. L., Aaskov, J. G. & Suhrbier, A. Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis. J. Gen. Virol. 77, 407\u2013411 (1996).","journal-title":"J. Gen. Virol."},{"key":"1333_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/cc8208","volume":"13","author":"JF Bermejo-Martin","year":"2009","unstructured":"Bermejo-Martin, J. F. et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit. Care 13, R201 (2009).","journal-title":"Crit. Care"},{"key":"1333_CR36","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/imcb.12492","volume":"99","author":"C Lu","year":"2021","unstructured":"Lu, C. & Chen, W. Influenza virus infection selectively triggers the accumulation and persistence of more potent Helios-expressing Foxp3+ regulatory T cells in the lungs. Immunol. Cell Biol. 99, 1011\u20131025 (2021).","journal-title":"Immunol. Cell Biol."},{"key":"1333_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005367","volume":"12","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. IL-17A promotes pulmonary B-1a cell differentiation via induction of Blimp-1 expression during influenza virus infection. PLOS Pathog. 12, e1005367 (2016).","journal-title":"PLOS Pathog."},{"key":"1333_CR38","doi-asserted-by":"publisher","first-page":"8227","DOI":"10.1073\/pnas.95.14.8227","volume":"95","author":"Y Takahashi","year":"1998","unstructured":"Takahashi, Y. et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc. Natl Acad. Sci. 95, 8227\u20138232 (1998).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1333_CR39","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.1128\/jvi.70.12.8485-8491.1996","volume":"70","author":"S Moffatt","year":"1996","unstructured":"Moffatt, S. et al. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J. Virol. 70, 8485\u20138491 (1996).","journal-title":"J. Virol."},{"key":"1333_CR40","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/01.MP.0000083145.68333.9B","volume":"16","author":"Y Mehraein","year":"2003","unstructured":"Mehraein, Y. et al. Detection of parvovirus B19 capsid proteins in lymphocytic cells in synovial tissue of autoimmune chronic arthritis. Mod. Pathol. 16, 811\u2013817 (2003).","journal-title":"Mod. Pathol."},{"key":"1333_CR41","doi-asserted-by":"publisher","first-page":"823659","DOI":"10.3389\/fimmu.2022.823659","volume":"13","author":"M Maslinska","year":"2022","unstructured":"Maslinska, M. & Kostyra-Grabczak, K. The role of virus infections in Sj\u00f6gren\u2019s syndrome. Front. Immunol.\u00a013, 823659 (2022).","journal-title":"Front. Immunol."},{"key":"1333_CR42","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cmi.2020.03.026","volume":"26","author":"N Petrosillo","year":"2020","unstructured":"Petrosillo, N., Viceconte, G., Ergonul, O., Ippolito, G. & Petersen, E. COVID-19, SARS and MERS: are they closely related? Clin. Microbiol. Infect. 26, 729\u2013734 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"1333_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00508-020-01760-4","volume":"133","author":"R da Rosa Mesquita","year":"2021","unstructured":"da Rosa Mesquita, R. et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wien. Klin. Wochenschr. 133, 377\u2013382 (2021).","journal-title":"Wien. Klin. Wochenschr."},{"key":"1333_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.idc.2022.01.003","volume":"36","author":"RA Hernandez Acosta","year":"2022","unstructured":"Hernandez Acosta, R. A., Esquer Garrigos, Z., Marcelin, J. R. & Vijayvargiya, P. COVID-19 pathogenesis and clinical manifestations. Infect. Dis. Clin. North. Am. 36, 231\u2013249 (2022).","journal-title":"Infect. Dis. Clin. North. Am."},{"key":"1333_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309316","volume":"19","author":"A Mageau","year":"2024","unstructured":"Mageau, A. et al. Risk of systemic lupus erythematosus flare after COVID-19 hospitalization: a matched cohort study. PLoS ONE 19, e0309316 (2024).","journal-title":"PLoS ONE"},{"key":"1333_CR46","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1111\/1756-185X.14657","volume":"26","author":"JA Naranjo-Mill\u00e1n","year":"2023","unstructured":"Naranjo-Mill\u00e1n, J. A., Bedoya-Joaqui, V. & Ca\u00f1as, C. A. Systemic lupus erythematosus flare during SARS-CoV-2 infection: Report of 3 cases presented during the fourth wave of the pandemic in Colombia. Int. J. Rheum. Dis. 26, 1807\u20131810 (2023).","journal-title":"Int. J. Rheum. Dis."},{"key":"1333_CR47","volume":"13","author":"MZ Khalid","year":"2021","unstructured":"Khalid, M. Z., Rogers, S., Fatima, A., Dawe, M. & Singh, R. A flare of systemic lupus erythematosus disease after COVID-19 infection: a case of lupus cerebritis. Cureus 13, e16104 (2021).","journal-title":"Cureus"},{"key":"1333_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152025","volume":"55","author":"M Di Iorio","year":"2022","unstructured":"Di Iorio, M. et al. DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: a prospective study. Semin. Arthritis Rheumatism 55, 152025 (2022).","journal-title":"Semin. Arthritis Rheumatism"},{"key":"1333_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08298-6","volume":"23","author":"KPJ van Dam","year":"2023","unstructured":"van Dam, K. P. J. et al. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity. BMC Infect. Dis. 23, 332 (2023).","journal-title":"BMC Infect. Dis."},{"key":"1333_CR50","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/annrheumdis-2020-217627","volume":"79","author":"C Ye","year":"2020","unstructured":"Ye, C. et al. Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China. Ann. Rheum. Dis. 79, 1007\u20131013 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1333_CR51","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/S2665-9913(20)30396-9","volume":"3","author":"L Perrot","year":"2021","unstructured":"Perrot, L. et al. First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 3, e6\u2013e8 (2021).","journal-title":"Lancet Rheumatol."},{"key":"1333_CR52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12969-021-00653-8","volume":"19","author":"B H\u00fcgle","year":"2021","unstructured":"H\u00fcgle, B., Krumrey-Langkammerer, M. & Haas, J.-P. Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication. Pediatr. Rheumatol. 19, 163 (2021).","journal-title":"Pediatr. Rheumatol."},{"key":"1333_CR53","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/acr.24768","volume":"75","author":"R Naddei","year":"2023","unstructured":"Naddei, R. et al. Increased relapse rate during COVID-19 lockdown in an Italian cohort of children with juvenile idiopathic arthritis. Arthritis Care Res. 75, 326\u2013331 (2023).","journal-title":"Arthritis Care Res."},{"key":"1333_CR54","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1080\/21505594.2021.1996059","volume":"12","author":"SW van Leur","year":"2021","unstructured":"van Leur, S. W., Tiaan, H., Deeksha, M. & Sanyal, S. Pathogenesis and virulence of flavivirus infections. Virulence 12, 2814\u20132838 (2021).","journal-title":"Virulence"},{"key":"1333_CR55","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2024.18","volume":"26","author":"AS Khazali","year":"2024","unstructured":"Khazali, A. S., Hadrawi, W. H., Ibrahim, F., Othman, S. & Nor Rashid, N. Thrombocytopenia in dengue infection: mechanisms and a potential application. Expert. Rev. Mol. Med. 26, e26 (2024).","journal-title":"Expert. Rev. Mol. Med."},{"key":"1333_CR56","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(23)02576-X","volume":"403","author":"G Paz-Bailey","year":"2024","unstructured":"Paz-Bailey, G., Adams, L. E., Deen, J., Anderson, K. B. & Katzelnick, L. C. Dengue. Lancet 403, 667\u2013682 (2024).","journal-title":"Lancet"},{"key":"1333_CR57","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200047","volume":"10","author":"AJ Davies","year":"2023","unstructured":"Davies, A. J. et al. Guillain-Barr\u00e9 syndrome following Zika virus infection is associated with a diverse spectrum of peripheral nerve reactive antibodies. Neurol. Neuroimmunol. Neuroinflamm 10, e200047 (2023).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"1333_CR58","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1177\/0961203316671816","volume":"26","author":"AF Zea-Vera","year":"2017","unstructured":"Zea-Vera, A. F. & Parra, B. Zika virus (ZIKV) infection related with immune thrombocytopenic purpura (ITP) exacerbation and antinuclear antibody positivity. Lupus 26, 890\u2013892 (2017).","journal-title":"Lupus"},{"key":"1333_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.onehlt.2023.100509","volume":"16","author":"Z Farooq","year":"2023","unstructured":"Farooq, Z. et al. European projections of West Nile virus transmission under climate change scenarios. One Health 16, 100509 (2023).","journal-title":"One Health"},{"key":"1333_CR60","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1111\/ajt.16595","volume":"21","author":"E McDonald","year":"2021","unstructured":"McDonald, E. et al. Surveillance for West Nile virus disease \u2014 United States, 2009\u20132018. Am. J. Transplant. 21, 1959\u20131974 (2021).","journal-title":"Am. J. Transplant."},{"key":"1333_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-229537","volume":"12","author":"NR Iyer","year":"2019","unstructured":"Iyer, N. R., McCune, W. J. & Wallace, B. I. West Nile encephalitis mimicking neuropsychiatric lupus in a patient with systemic lupus erythematosus. BMJ Case Rep. 12, e229537 (2019).","journal-title":"BMJ Case Rep."},{"key":"1333_CR62","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.4269\/ajtmh.21-0041","volume":"104","author":"M Schiuma","year":"2021","unstructured":"Schiuma, M. et al. Case report: a fatal case of West Nile virus meningoencephalomyelitis in a woman with systemic lupus erythematosus initially misdiagnosed as SARS-CoV-2 infection. Am. J. Trop. Med. Hyg. 104, 1716\u20131718 (2021).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1333_CR63","doi-asserted-by":"publisher","first-page":"10118","DOI":"10.1128\/JVI.75.21.10118-10131.2001","volume":"75","author":"AM Powers","year":"2001","unstructured":"Powers, A. M. et al. Evolutionary relationships and systematics of the alphaviruses. J. Virol. 75, 10118\u201310131 (2001).","journal-title":"J. Virol."},{"key":"1333_CR64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.7861\/clinmedicine.16-2-129","volume":"16","author":"M Marks","year":"2016","unstructured":"Marks, M. & Marks, J. L. Viral arthritis. Clin. Med. 16, 129\u2013134 (2016).","journal-title":"Clin. Med."},{"key":"1333_CR65","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2396484","volume":"15","author":"W Freppel","year":"2024","unstructured":"Freppel, W. et al. Pathogenicity and virulence of chikungunya virus. Virulence 15, 2396484 (2024).","journal-title":"Virulence"},{"key":"1333_CR66","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/acr.22900","volume":"68","author":"AJ Rodr\u00edguez-Morales","year":"2016","unstructured":"Rodr\u00edguez-Morales, A. J., Cardona-Ospina, J. A., Fernanda Urbano-Garz\u00f3n, S. & Sebastian Hurtado-Zapata, J. Prevalence of post-chikungunya infection chronic inflammatory arthritis: a systematic review and meta-analysis. Arthritis Care Res. 68, 1849\u20131858 (2016).","journal-title":"Arthritis Care Res."},{"key":"1333_CR67","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/art.39027","volume":"67","author":"JJ Miner","year":"2015","unstructured":"Miner, J. J. et al. Brief report: Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol. 67, 1214\u20131220 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1333_CR68","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/j.amjmed.2019.10.005","volume":"133","author":"JK Amaral","year":"2020","unstructured":"Amaral, J. K., Bilsborrow, J. B. & Schoen, R. T. Chronic chikungunya arthritis and rheumatoid arthritis: what they have in common. Am. J. Med. 133, e91\u2013e97 (2020).","journal-title":"Am. J. Med."},{"key":"1333_CR69","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1002\/art.39775","volume":"68","author":"M Blettery","year":"2016","unstructured":"Blettery, M. et al. Brief report: management of chronic post-chikungunya rheumatic disease: the Martinican experience. Arthritis Rheumatol. 68, 2817\u20132824 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1333_CR70","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1002\/jmv.26990","volume":"93","author":"M Javanian","year":"2021","unstructured":"Javanian, M. et al. A brief review of influenza virus infection. J. Med. Virol. 93, 4638\u20134646 (2021).","journal-title":"J. Med. Virol."},{"key":"1333_CR71","first-page":"311","volume":"30","author":"VK Bournia","year":"2012","unstructured":"Bournia, V. K., Sfontouris, C., Konsta, M. & Iliopoulos, A. H1N1 influenza outcome in rheumatic patients under biological therapy. Clin. Exp. Rheumatol. 30, 311\u2013312 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1333_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-358","volume":"11","author":"K Tselios","year":"2011","unstructured":"Tselios, K., Tsioka, R., Sarantopoulos, A., Mouloudi, E. & Boura, P. Influenza A\/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report. BMC Infect. Dis. 11, 358 (2011).","journal-title":"BMC Infect. Dis."},{"key":"1333_CR73","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/archdermatol.2010.96","volume":"146","author":"MC Kling","year":"2010","unstructured":"Kling, M. C., Larian, A. A., Scordi-Bello, I., Emer, J. & Lebwohl, M. G. Fatal influenza A(H1N1) respiratory tract infection in a patient having psoriasis treated with infliximab. Arch. Dermatol. 146, 651\u2013654 (2010).","journal-title":"Arch. Dermatol."},{"key":"1333_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84153-5","volume":"11","author":"YB Joo","year":"2021","unstructured":"Joo, Y. B., Kim, K. J., Park, K. S. & Park, Y. J. Influenza infection as a trigger for systemic lupus erythematosus flares resulting in hospitalization. Sci. Rep. 11, 4630 (2021).","journal-title":"Sci. Rep."},{"key":"1333_CR75","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.dmih2-0008-2015","author":"ML Landry","year":"2016","unstructured":"Landry, M. L. Parvovirus B19. Microbiol. Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.dmih2-0008-2015 (2016).","journal-title":"Microbiol. Spectr."},{"key":"1333_CR76","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4149\/av_2014_03_199","volume":"58","author":"LD Rogo","year":"2014","unstructured":"Rogo, L. D., Mokhtari-Azad, T., Kabir, M. H. & Rezaei, F. Human parvovirus B19: a review. Acta Virol. 58, 199\u2013213 (2014).","journal-title":"Acta Virol."},{"key":"1333_CR77","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1136\/ard.45.10.832","volume":"45","author":"BJ Cohen","year":"1986","unstructured":"Cohen, B. J. et al. Human parvovirus infection in early rheumatoid and inflammatory arthritis. Ann. Rheum. Dis. 45, 832\u2013838 (1986).","journal-title":"Ann. Rheum. Dis."},{"key":"1333_CR78","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.4103\/jfmpc.jfmpc_25_19","volume":"8","author":"V Alexander","year":"2019","unstructured":"Alexander, V., Das, S., Mangan, A. S. & Iyadurai, R. Acute parvovirus B19 infection presenting as rheumatoid arthritis mimic. J. Fam. Med. Prim. Care 8, 1257\u20131259 (2019).","journal-title":"J. Fam. Med. Prim. Care"},{"key":"1333_CR79","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.semarthrit.2004.07.008","volume":"34","author":"P S\u00e8ve","year":"2005","unstructured":"S\u00e8ve, P. et al. Lupus-like presentation of parvovirus B19 infection. Semin. Arthritis Rheum. 34, 642\u2013648 (2005).","journal-title":"Semin. Arthritis Rheum."},{"key":"1333_CR80","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1386-6532(99)00038-4","volume":"14","author":"A Hemauer","year":"1999","unstructured":"Hemauer, A., Beckenlehner, K., Wolf, H., Lang, B. & Modrow, S. Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient. J. Clin. Virol. 14, 73\u201377 (1999).","journal-title":"J. Clin. Virol."},{"key":"1333_CR81","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0049-0172(95)80001-8","volume":"24","author":"G Nesher","year":"1995","unstructured":"Nesher, G., Osborn, T. G. & Moore, T. L. Parvovirus infection mimicking systemic lupus erythematosus. Semin. Arthritis Rheum. 24, 297\u2013303 (1995).","journal-title":"Semin. Arthritis Rheum."},{"key":"1333_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15409","volume":"27","author":"F Hassan","year":"2024","unstructured":"Hassan, F. et al. Rheumatic manifestations and sequela of acute parvovirus B19 infection in hospitalized adult population. Int. J. Rheum. Dis. 27, e15409 (2024).","journal-title":"Int. J. Rheum. Dis."},{"key":"1333_CR83","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/096120339100100107","volume":"1","author":"O Meyer","year":"1991","unstructured":"Meyer, O. et al. Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi\u2019s disease) associated with systemic lupus erythematosus. Lupus 1, 37\u201341 (1991).","journal-title":"Lupus"},{"key":"1333_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113960","volume":"147","author":"C-C Tzang","year":"2025","unstructured":"Tzang, C.-C. et al. Clinical implications of human Parvovirus B19 infection on autoimmunity and autoimmune diseases. Int. Immunopharmacol. 147, 113960 (2025).","journal-title":"Int. Immunopharmacol."},{"key":"1333_CR85","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192048","volume":"217","author":"LS Taams","year":"2020","unstructured":"Taams, L. S. Interleukin-17 in rheumatoid arthritis: trials and tribulations. J. Exp. Med. 217, e20192048 (2020).","journal-title":"J. Exp. Med."},{"key":"1333_CR86","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.21749","volume":"54","author":"BW Kirkham","year":"2006","unstructured":"Kirkham, B. W. et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum. 54, 1122\u20131131 (2006).","journal-title":"Arthritis Rheum."},{"key":"1333_CR87","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3899\/jrheum.101355","volume":"38","author":"H YAMADA","year":"2011","unstructured":"YAMADA, H. et al. Preferential accumulation of activated th1 cells not only in rheumatoid arthritis but also in osteoarthritis joints. J. Rheumatol. 38, 1569\u20131575 (2011).","journal-title":"J. Rheumatol."},{"key":"1333_CR88","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1084\/jem.20071397","volume":"204","author":"K Hirota","year":"2007","unstructured":"Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803\u20132812 (2007).","journal-title":"J. Exp. Med."},{"key":"1333_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45213-2","volume":"15","author":"KF Baker","year":"2024","unstructured":"Baker, K. F. et al. Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission. Nat. Commun. 15, 1063 (2024).","journal-title":"Nat. Commun."},{"key":"1333_CR90","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1056\/NEJMoa2004114","volume":"383","author":"DE Orange","year":"2020","unstructured":"Orange, D. E. et al. RNA Identification of PRIME cells predicting rheumatoid arthritis flares. N. Engl. J. Med. 383, 218\u2013228 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1333_CR91","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1302\/2046-3758.117.BJR-2021-0594.R1","volume":"11","author":"P Luo","year":"2022","unstructured":"Luo, P. et al. Immunomodulatory role of T helper cells in rheumatoid arthritis : a comprehensive research review. Bone Jt Res. 11, 426\u2013438 (2022).","journal-title":"Bone Jt Res."},{"key":"1333_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01713-6","volume":"16","author":"R Zhao","year":"2023","unstructured":"Zhao, R. et al. Genetic association between interleukin-17 and susceptibility to rheumatoid arthritis. BMC Med. Genomics 16, 277 (2023).","journal-title":"BMC Med. Genomics"},{"key":"1333_CR93","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.clim.2010.10.002","volume":"138","author":"G Zizzo","year":"2011","unstructured":"Zizzo, G. et al. Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. Clin. Immunol. 138, 107\u2013116 (2011).","journal-title":"Clin. Immunol."},{"key":"1333_CR94","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1002\/art.34631","volume":"64","author":"HI Nakaya","year":"2012","unstructured":"Nakaya, H. I. et al. Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis. Arthritis Rheumatism 64, 3553\u20133563 (2012).","journal-title":"Arthritis Rheumatism"},{"key":"1333_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006985","volume":"14","author":"A Gangaplara","year":"2018","unstructured":"Gangaplara, A. et al. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment. PLoS Pathog. 14, e1006985 (2018).","journal-title":"PLoS Pathog."},{"key":"1333_CR96","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775\u2013787 (2008).","journal-title":"Cell"},{"key":"1333_CR97","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2249.1993.tb05992.x","volume":"94","author":"M SHINGU","year":"2008","unstructured":"SHINGU, M. et al. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin. Exp. Immunol. 94, 145\u2013149 (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"1333_CR98","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1056\/NEJM200103223441207","volume":"344","author":"EHS Choy","year":"2001","unstructured":"Choy, E. H. S. & Panayi, G. S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344, 907\u2013916 (2001).","journal-title":"N. Engl. J. Med."},{"key":"1333_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-93","volume":"15","author":"S Sun","year":"2014","unstructured":"Sun, S. et al. The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases. BMC Musculoskelet. Disord. 15, 93 (2014).","journal-title":"BMC Musculoskelet. Disord."},{"key":"1333_CR100","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/rheumatology\/kei208","volume":"45","author":"C-H Chen","year":"2005","unstructured":"Chen, C.-H. et al. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology 45, 414\u2013420 (2005).","journal-title":"Rheumatology"},{"key":"1333_CR101","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/art.20696","volume":"51","author":"C Yang","year":"2004","unstructured":"Yang, C. et al. Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis. Arthritis Care Res. 51, 691\u2013699 (2004).","journal-title":"Arthritis Care Res."},{"key":"1333_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2022.105388","volume":"206","author":"T Feng","year":"2022","unstructured":"Feng, T. et al. Matrix metalloproteinase 3 restricts viral infection by enhancing host antiviral immunity. Antivir. Res. 206, 105388 (2022).","journal-title":"Antivir. Res."},{"key":"1333_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084748","volume":"9","author":"X Zuo","year":"2014","unstructured":"Zuo, X., Pan, W., Feng, T., Shi, X. & Dai, J. Matrix Metalloproteinase 3 promotes cellular anti-dengue virus response via interaction with transcription factor NF\u03baB in cell nucleus. PLOS ONE 9, e84748 (2014).","journal-title":"PLOS ONE"},{"key":"1333_CR104","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett, G. & Gravallese, E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat. Rev. Rheumatol. 8, 656\u2013664 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1333_CR105","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1759720X12438080","volume":"4","author":"P Geusens","year":"2012","unstructured":"Geusens, P. The role of RANK ligand\/osteoprotegerin in rheumatoid arthritis. Ther. Adv. Musculoskelet. Dis. 4, 225\u2013233 (2012).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"1333_CR106","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1210\/en.2004-1167","volume":"146","author":"X-H Liu","year":"2005","unstructured":"Liu, X.-H., Kirschenbaum, A., Yao, S. & Levine, A. C. Cross-talk between the interleukin-6 and prostaglandin E2 signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin\/receptor activator of nuclear factor-\u03baB (RANK) ligand\/RANK system. Endocrinology 146, 1991\u20131998 (2005).","journal-title":"Endocrinology"},{"key":"1333_CR107","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1172\/JCI11176","volume":"106","author":"J Lam","year":"2000","unstructured":"Lam, J. et al. TNF-\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Investig. 106, 1481\u20131488 (2000).","journal-title":"J. Clin. Investig."},{"key":"1333_CR108","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.1073\/pnas.1318859111","volume":"111","author":"W Chen","year":"2014","unstructured":"Chen, W. et al. Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. Proc. Natl Acad. Sci. 111, 6040\u20136045 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"1333_CR109","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/infdis\/jis368","volume":"206","author":"M Noret","year":"2012","unstructured":"Noret, M. et al. Interleukin 6, RANKL, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts. J. Infect. Dis. 206, 455\u2013457 (2012).","journal-title":"J. Infect. Dis."},{"key":"1333_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35422-3","volume":"8","author":"N Mumtaz","year":"2018","unstructured":"Mumtaz, N. et al. Zika virus infection perturbs osteoblast function. Sci. Rep. 8, 16975 (2018).","journal-title":"Sci. Rep."},{"key":"1333_CR111","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/v17020143","volume":"17","author":"RN Freiberger","year":"2025","unstructured":"Freiberger, R. N. et al. SARS-CoV-2 impairs osteoblast differentiation through spike glycoprotein and cytokine dysregulation. Viruses 17, 143 (2025).","journal-title":"Viruses"},{"key":"1333_CR112","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ebiom.2019.05.014","volume":"44","author":"VN Camargos","year":"2019","unstructured":"Camargos, V. N. et al. In-depth characterization of congenital Zika syndrome in immunocompetent mice: antibody-dependent enhancement and an antiviral peptide therapy. eBioMedicine 44, 516\u2013529 (2019).","journal-title":"eBioMedicine"},{"key":"1333_CR113","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1006\/bbrc.1998.9788","volume":"253","author":"N Nakagawa","year":"1998","unstructured":"Nakagawa, N. et al. RANK Is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem. Biophys. Res. Commun. 253, 395\u2013400 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1333_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109902","volume":"37","author":"MH Chang","year":"2021","unstructured":"Chang, M. H. et al. Arthritis flares mediated by tissue-resident memory T cells in the joint. Cell Rep. 37, 109902 (2021).","journal-title":"Cell Rep."},{"key":"1333_CR115","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000025023","volume":"43","author":"L Mateo","year":"2000","unstructured":"Mateo, L. et al. An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8. Intervirology 43, 55\u201360 (2000).","journal-title":"Intervirology"},{"key":"1333_CR116","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/ijms26051851","volume":"26","author":"J Sep\u00falveda-Delgado","year":"2025","unstructured":"Sep\u00falveda-Delgado, J., Llorente, L. & Hern\u00e1ndez-Do\u00f1o, S. A comprehensive review of Fc gamma receptors and their role in systemic lupus erythematosus. Int. J. Mol. Sci. 26, 1851 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"1333_CR117","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nri856","volume":"2","author":"T Takai","year":"2002","unstructured":"Takai, T. Roles of Fc receptors in autoimmunity. Nat. Rev. Immunol. 2, 580\u2013592 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"1333_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2025.100269","volume":"10","author":"M Fehringer","year":"2025","unstructured":"Fehringer, M. & Vogl, T. Molecular mimicry in the pathogenesis of autoimmune rheumatic diseases. J. Transl. Autoimmun. 10, 100269 (2025).","journal-title":"J. Transl. Autoimmun."},{"key":"1333_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53658-8","volume":"15","author":"C Maguire","year":"2024","unstructured":"Maguire, C. et al. Molecular mimicry as a mechanism of viral immune evasion and autoimmunity. Nat. Commun. 15, 9403 (2024).","journal-title":"Nat. Commun."},{"key":"1333_CR120","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s10930-020-09901-4","volume":"39","author":"FK Yoshimoto","year":"2020","unstructured":"Yoshimoto, F. K. The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19. Protein J. 39, 198\u2013216 (2020).","journal-title":"Protein J."},{"key":"1333_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115175","volume":"165","author":"EA Bhat","year":"2023","unstructured":"Bhat, E. A., Ali, T., Sajjad, N., Kumar, R. & Bron, P. Insights into the structure, functional perspective, and pathogenesis of ZIKV: an updated review. Biomed. Pharmacother. 165, 115175 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"1333_CR122","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1177\/0961203316645205","volume":"25","author":"G Stojan","year":"2016","unstructured":"Stojan, G. & Petri, M. Anti-C1q in systemic lupus erythematosus. Lupus 25, 873\u2013877 (2016).","journal-title":"Lupus"},{"key":"1333_CR123","doi-asserted-by":"publisher","first-page":"27293","DOI":"10.1039\/C8RA04760J","volume":"8","author":"A Singh","year":"2018","unstructured":"Singh, A., Kumar, A., Uversky, V. N. & Giri, R. Understanding the interactability of chikungunya virus proteins via molecular recognition feature analysis. RSC Adv. 8, 27293\u201327303 (2018).","journal-title":"RSC Adv."},{"key":"1333_CR124","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056246","volume":"8","author":"S Biswas","year":"2013","unstructured":"Biswas, S. et al. Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach. PLoS ONE 8, e56246 (2013).","journal-title":"PLoS ONE"},{"key":"1333_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/ar754","volume":"5","author":"S Ooka","year":"2003","unstructured":"Ooka, S., Matsui, T., Nishioka, K. & Kato, T. Autoantibodies to low-density-lipoprotein-receptor-related protein 2 (LRP2) in systemic autoimmune diseases. Arthritis Res. Ther. 5, R174 (2003).","journal-title":"Arthritis Res. Ther."},{"key":"1333_CR126","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/1529-0131(200104)44:4<838::AID-ANR140>3.0.CO;2-C","volume":"44","author":"J Tsuruha","year":"2001","unstructured":"Tsuruha, J. et al. Implication of cartilage intermediate layer protein in cartilage destruction in subsets of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 44, 838\u2013845 (2001).","journal-title":"Arthritis Rheum."},{"key":"1333_CR127","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41392-022-00981-5","volume":"7","author":"S Su","year":"2022","unstructured":"Su, S. et al. Modulation of innate immune response to viruses including SARS-CoV-2 by progesterone. Signal. Transduct. Target. Ther. 7, 137 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1333_CR128","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.4049\/jimmunol.1001958","volume":"186","author":"M Fijak","year":"2011","unstructured":"Fijak, M. et al. Testosterone replacement effectively inhibits the development of experimental autoimmune orchitis in rats: evidence for a direct role of testosterone on regulatory T cell expansion. J. Immunol. 186, 5162\u20135172 (2011).","journal-title":"J. Immunol."},{"key":"1333_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155400","volume":"138","author":"CA Lopez-Acevo","year":"2021","unstructured":"Lopez-Acevo, C. A. et al. Cortisol and perceived stress are associated with cytokines levels in patients infected with influenza B virus. Cytokine 138, 155400 (2021).","journal-title":"Cytokine"},{"key":"1333_CR130","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1196\/annals.1351.019","volume":"1069","author":"TK Kvien","year":"2006","unstructured":"Kvien, T. K., Uhlig, T., \u00d8deg\u00e5rd, S. & Heiberg, M. S. Epidemiological aspects of rheumatoid arthritis. Ann. N. Y. Acad. Sci. 1069, 212\u2013222 (2006).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1333_CR131","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","volume":"384","author":"L Lisnevskaia","year":"2014","unstructured":"Lisnevskaia, L., Murphy, G. & Isenberg, D. Systemic lupus erythematosus. Lancet 384, 1878\u20131888 (2014).","journal-title":"Lancet"},{"key":"1333_CR132","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00004","volume":"142","author":"JP Buyon","year":"2005","unstructured":"Buyon, J. P. et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann. Intern. Med. 142, 953\u2013962 (2005).","journal-title":"Ann. Intern. Med."},{"key":"1333_CR133","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1172\/JCI0214873","volume":"109","author":"CM Grimaldi","year":"2002","unstructured":"Grimaldi, C. M., Cleary, J., Dagtas, A. S., Moussai, D. & Diamond, B. Estrogen alters thresholds for B cell apoptosis and activation. J. Clin. Invest. 109, 1625\u20131633 (2002).","journal-title":"J. Clin. Invest."},{"key":"1333_CR134","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2119\/molmed.2010.00172","volume":"17","author":"L Hill","year":"2011","unstructured":"Hill, L., Jeganathan, V., Chinnasamy, P., Grimaldi, C. & Diamond, B. Differential roles of estrogen receptors \u03b1 and \u03b2 in control of B-cell maturation and selection. Mol. Med. 17, 211\u2013220 (2011).","journal-title":"Mol. Med."},{"key":"1333_CR135","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/gene.2009.12","volume":"10","author":"A Hewagama","year":"2009","unstructured":"Hewagama, A., Patel, D., Yarlagadda, S., Strickland, F. M. & Richardson, B. C. Stronger inflammatory\/cytotoxic T-cell response in women identified by microarray analysis. Genes. Immun. 10, 509\u2013516 (2009).","journal-title":"Genes. Immun."},{"key":"1333_CR136","doi-asserted-by":"publisher","first-page":"L415","DOI":"10.1152\/ajplung.00398.2015","volume":"310","author":"J Peretz","year":"2016","unstructured":"Peretz, J., Pekosz, A., Lane, A. P. & Klein, S. L. Estrogenic compounds reduce influenza A virus replication in primary human nasal epithelial cells derived from female, but not male, donors. Am. J. Physiol. Lung Cell Mol. Physiol. 310, L415\u2013L425 (2016).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"1333_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13585-4","volume":"12","author":"F Li","year":"2022","unstructured":"Li, F. et al. Estrogen hormone is an essential sex factor inhibiting inflammation and immune response in COVID-19. Sci. Rep. 12, 9462 (2022).","journal-title":"Sci. Rep."},{"key":"1333_CR138","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/fampra\/cmac041","volume":"39","author":"H Dambha-Miller","year":"2022","unstructured":"Dambha-Miller, H. et al. Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study. Fam. Pract. 39, 1049\u20131055 (2022).","journal-title":"Fam. Pract."},{"key":"1333_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-020-01851-z","volume":"18","author":"U Seeland","year":"2020","unstructured":"Seeland, U. et al. Evidence for treatment with estradiol for women with SARS-CoV-2 infection. BMC Med. 18, 1\u20139 (2020).","journal-title":"BMC Med."},{"key":"1333_CR140","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/ard.2006.056937","volume":"66","author":"K Forslind","year":"2007","unstructured":"Forslind, K., Hafstr\u00f6m, I., Ahlm\u00e9n, M. & Svensson, B. Sex: a major predictor of remission in early rheumatoid arthritis? Ann. Rheum. Dis. 66, 46\u201352 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"1333_CR141","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/annrheumdis-2012-202781","volume":"73","author":"M Pikwer","year":"2014","unstructured":"Pikwer, M. et al. Association between testosterone levels and risk of future rheumatoid arthritis in men: a population-based case\u2013control study. Ann. Rheum. Dis. 73, 573\u2013579 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1333_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.1780340102","volume":"34","author":"M Cutolo","year":"1991","unstructured":"Cutolo, M., Balleari, E., Giusti, M., Intra, E. & Accardo, S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum. 34, 1\u20135 (1991).","journal-title":"Arthritis Rheum."},{"key":"1333_CR143","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/andr.13097","volume":"10","author":"A Salonia","year":"2022","unstructured":"Salonia, A. et al. Testosterone in males with COVID-19: a 7-month cohort study. Andrology 10, 34\u201341 (2022).","journal-title":"Andrology"},{"key":"1333_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105300","volume":"25","author":"B Zheng","year":"2022","unstructured":"Zheng, B. et al. Testosterone protects mice against Zika virus infection and suppresses the inflammatory response in the brain. iScience 25, 105300 (2022).","journal-title":"iScience"},{"key":"1333_CR145","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1710-1492-4-1-2","volume":"4","author":"FS Dhabhar","year":"2008","unstructured":"Dhabhar, F. S. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection versus immunopathology. Allergy Asthma Clin. Immunol. 4, 2\u201311 (2008).","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"1333_CR146","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00296-023-05296-4","volume":"43","author":"A Wr\u00f3bel","year":"2023","unstructured":"Wr\u00f3bel, A., Szklarczyk, J., Bara\u0144ska, I., Majda, A. & Jaworek, J. Association between levels of serotonin, melatonin, cortisol and the clinical condition of patients with rheumatoid arthritis. Rheumatol. Int. 43, 859\u2013866 (2023).","journal-title":"Rheumatol. Int."},{"key":"1333_CR147","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/art.20747","volume":"52","author":"RH Straub","year":"2005","unstructured":"Straub, R. H., Dhabhar, F. S., Bijlsma, J. W. J. & Cutolo, M. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthritis Rheum. 52, 16\u201326 (2005).","journal-title":"Arthritis Rheum."},{"key":"1333_CR148","doi-asserted-by":"publisher","first-page":"39","DOI":"10.47162\/RJME.63.1.03","volume":"63","author":"M Popescu","year":"2022","unstructured":"Popescu, M. et al. COVID-19 infection: from stress-related cortisol levels to adrenal glands infarction. Rom. J. Morphol. Embryol. 63, 39\u201348 (2022).","journal-title":"Rom. J. Morphol. Embryol."},{"key":"1333_CR149","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1530\/EJE-21-1171","volume":"186","author":"C Wenzek","year":"2022","unstructured":"Wenzek, C. et al. The interplay of thyroid hormones and the immune system \u2014 where we stand and why we need to know about it. Eur. J. Endocrinol. 186, R65\u2013R77 (2022).","journal-title":"Eur. J. Endocrinol."},{"key":"1333_CR150","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1177\/0961203311401456","volume":"20","author":"H Gao","year":"2011","unstructured":"Gao, H. et al. Subclinical hypothyroidism and its association with lupus nephritis: a case control study in a large cohort of Chinese systemic lupus erythematosus patients. Lupus 20, 1035\u20131041 (2011).","journal-title":"Lupus"},{"key":"1333_CR151","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/art.1780301006","volume":"30","author":"FW Miller","year":"1987","unstructured":"Miller, F. W., Moore, G. F., Weintraub, B. D. & Steinberg, A. D. Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus. Arthritis Rheum. 30, 1124\u20131130 (1987).","journal-title":"Arthritis Rheum."},{"key":"1333_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1015516","volume":"13","author":"YJ Liu","year":"2022","unstructured":"Liu, Y. J., Miao, H. B., Lin, S. & Chen, Z. Association between rheumatoid arthritis and thyroid dysfunction: a meta-analysis and systematic review. Front. Endocrinol. 13, 1015516 (2022).","journal-title":"Front. Endocrinol."},{"key":"1333_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49743-4","volume":"9","author":"A-S P\u00f6rings","year":"2019","unstructured":"P\u00f6rings, A.-S., Lowin, T., Dufner, B., Grifka, J. & Straub, R. H. A thyroid hormone network exists in synovial fibroblasts of rheumatoid arthritis and osteoarthritis patients. Sci. Rep. 9, 13235 (2019).","journal-title":"Sci. Rep."},{"key":"1333_CR154","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.celrep.2018.10.025","volume":"25","author":"YH Wu","year":"2018","unstructured":"Wu, Y. H. et al. Zika virus infection in hypothalamus causes hormone deficiencies and leads to irreversible growth delay and memory impairment in mice. Cell Rep. 25, 1537\u20131547.e1534 (2018).","journal-title":"Cell Rep."},{"key":"1333_CR155","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1750-3639.2007.00080.x","volume":"17","author":"HB Armah","year":"2007","unstructured":"Armah, H. B. et al. Systemic distribution of West Nile virus infection: postmortem immunohistochemical study of six cases. Brain Pathol. 17, 354\u2013362 (2007).","journal-title":"Brain Pathol."},{"key":"1333_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.938633","volume":"13","author":"T Weider","year":"2022","unstructured":"Weider, T. et al. High prevalence of common human viruses in thyroid tissue. Front. Endocrinol. 13, 938633 (2022).","journal-title":"Front. Endocrinol."},{"key":"1333_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fdsfr.2022.881556","author":"ER Soriano","year":"2022","unstructured":"Soriano, E. R. Current status and future challenges in the treatment of rheumatic diseases. Front. Drug Saf. Regul. https:\/\/doi.org\/10.3389\/fdsfr.2022.881556 (2022).","journal-title":"Front. Drug Saf. Regul."},{"key":"1333_CR158","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2217\/ijr.12.82","volume":"8","author":"EV Rozenblyum","year":"2013","unstructured":"Rozenblyum, E. V., Allen, U. D., Silverman, E. D. & Levy, D. M. Cytomegalovirus infection in childhood-onset systemic lupus erythematosus. Int. J. Clin. Rheumatol. 8, 137\u2013146 (2013).","journal-title":"Int. J. Clin. Rheumatol."},{"key":"1333_CR159","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41584-022-00904-2","volume":"19","author":"JJ Miner","year":"2023","unstructured":"Miner, J. J. & Fitzgerald, K. A. A path towards personalized medicine for autoinflammatory and related diseases. Nat. Rev. Rheumatol. 19, 182\u2013189 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1333_CR160","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of covid-19 \u2014 final report. N. Engl. J. Med. 383, 1813\u20131826 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1333_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2025.107009","volume":"275","author":"AR Lee","year":"2025","unstructured":"Lee, A. R. et al. Remdesivir alleviates joint damage in collagen-induced arthritis and inhibits inflammatory cell death of RA synovial fibroblasts. Immunol. Lett. 275, 107009 (2025).","journal-title":"Immunol. Lett."},{"key":"1333_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102468","volume":"111","author":"C Perricone","year":"2020","unstructured":"Perricone, C. et al. The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19. J. Autoimmun. 111, 102468 (2020).","journal-title":"J. Autoimmun."},{"key":"1333_CR163","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","volume":"384","author":"AC Kalil","year":"2021","unstructured":"Kalil, A. C. et al. Baricitinib plus remdesivir for hospitalized adults with Covid-19. N. Engl. J. Med. 384, 795\u2013807 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1333_CR164","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cell.2020.11.007","volume":"184","author":"TN Hoang","year":"2021","unstructured":"Hoang, T. N. et al. Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques. Cell 184, 460\u2013475.e421 (2021).","journal-title":"Cell"},{"key":"1333_CR165","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/jcm7120549","volume":"7","author":"A Traish","year":"2018","unstructured":"Traish, A., Bolanos, J., Nair, S., Saad, F. & Morgentaler, A. Do androgens modulate the pathophysiological pathways of inflammation? Appraising the contemporary evidence. J. Clin. Med. 7, 549 (2018).","journal-title":"J. Clin. Med."},{"key":"1333_CR166","first-page":"23","volume":"2024","author":"A Amodeo","year":"2024","unstructured":"Amodeo, A., Persani, L., Bonomi, M. & Cangiano, B. Use of testosterone replacement therapy to treat long-COVID-related hypogonadism. Endocrinol. Diabetes Metab. Case Rep. 2024, 23\u20130097 (2024).","journal-title":"Endocrinol. Diabetes Metab. Case Rep."},{"key":"1333_CR167","doi-asserted-by":"publisher","first-page":"bvaf002","DOI":"10.1210\/jendso\/bvaf002","volume":"9","author":"KM Pencina","year":"2025","unstructured":"Pencina, K. M. et al. Testosterone replacement therapy and risk of COVID-19 and effect of COVID-19 on testosterone\u2019s treatment effect. J. Endocr. Soc. 9, bvaf002 (2025).","journal-title":"J. Endocr. Soc."},{"key":"1333_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/srep30187","volume":"6","author":"D-d Qin","year":"2016","unstructured":"Qin, D. -d et al. Prolonged secretion of cortisol as a possible mechanism underlying stress and depressive behaviour. Sci. Rep. 6, 30187 (2016).","journal-title":"Sci. Rep."},{"key":"1333_CR169","first-page":"171","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren, M. B., Lamkin, D. M. & Suls, J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Biopsychosoc. Sci. Med. 71, 171\u2013186 (2009).","journal-title":"Biopsychosoc. Sci. Med."},{"key":"1333_CR170","first-page":"715","volume":"71","author":"LM Thornton","year":"2009","unstructured":"Thornton, L. M., Andersen, B. L., Schuler, T. A. & Carson, W. E. I. A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial. Biopsychosoc. Sci. Med. 71, 715\u2013724 (2009).","journal-title":"Biopsychosoc. Sci. Med."},{"key":"1333_CR171","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/art.10416","volume":"47","author":"JA Astin","year":"2002","unstructured":"Astin, J. A., Beckner, W., Soeken, K., Hochberg, M. C. & Berman, B. Psychological interventions for rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheum. 47, 291\u2013302 (2002).","journal-title":"Arthritis Rheum."},{"key":"1333_CR172","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/acr.20251","volume":"62","author":"K Knittle","year":"2010","unstructured":"Knittle, K., Maes, S. & de Gucht, V. Psychological interventions for rheumatoid arthritis: examining the role of self-regulation with a systematic review and meta-analysis of randomized controlled trials. Arthritis Care Res. 62, 1460\u20131472 (2010).","journal-title":"Arthritis Care Res."},{"key":"1333_CR173","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijnurstu.2018.03.008","volume":"82","author":"L Prothero","year":"2018","unstructured":"Prothero, L., Barley, E., Galloway, J., Georgopoulou, S. & Sturt, J. The evidence base for psychological interventions for rheumatoid arthritis: a systematic review of reviews. Int. J. Nurs. Stud. 82, 20\u201329 (2018).","journal-title":"Int. J. Nurs. Stud."},{"key":"1333_CR174","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1365-2567.2001.01335.x","volume":"104","author":"M Peakman","year":"2001","unstructured":"Peakman, M. & Dayan, C. M. Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire? Immunology 104, 361\u2013366 (2001).","journal-title":"Immunology"},{"key":"1333_CR175","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa9301","volume":"7","author":"H Benham","year":"2015","unstructured":"Benham, H. et al. Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci. Transl. Med. 7, 290ra287 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1333_CR176","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fimmu.2019.00148","volume":"10","author":"BE Phillips","year":"2019","unstructured":"Phillips, B. E., Garciafigueroa, Y., Engman, C., Trucco, M. & Giannoukakis, N. Tolerogenic dendritic cells and T-regulatory cells at the clinical trials crossroad for the treatment of autoimmune disease; emphasis on type 1 diabetes therapy. Front. Immunol. 10, 148 (2019).","journal-title":"Front. Immunol."},{"key":"1333_CR177","doi-asserted-by":"publisher","first-page":"661875","DOI":"10.3389\/fimmu.2021.661875","volume":"12","author":"C Selck","year":"2021","unstructured":"Selck, C. & Dominguez-Villar, M. Antigen-specific regulatory t cell therapy in autoimmune diseases and transplantation. Front. Immunol.\u00a012, 661875 (2021).","journal-title":"Front. Immunol."},{"key":"1333_CR178","doi-asserted-by":"publisher","first-page":"645632","DOI":"10.3389\/fimmu.2021.645632","volume":"12","author":"S Li","year":"2021","unstructured":"Li, S. et al. Applications of protein microarrays in biomarker discovery for autoimmune diseases. Front. Immunol.\u00a012, 645632 (2021).","journal-title":"Front. Immunol"},{"key":"1333_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2013.01.013","volume":"43","author":"HB Larman","year":"2013","unstructured":"Larman, H. B. et al. PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis. J. Autoimmun. 43, 1\u20139 (2013).","journal-title":"J. Autoimmun."},{"key":"1333_CR180","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41551-022-00925-y","volume":"6","author":"JJ Credle","year":"2022","unstructured":"Credle, J. J. et al. Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries. Nat. Biomed. Eng. 6, 992\u20131003 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"1333_CR181","doi-asserted-by":"publisher","first-page":"M110.005033","DOI":"10.1074\/mcp.M110.005033","volume":"10","author":"A Carlsson","year":"2011","unstructured":"Carlsson, A. et al. Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays. Mol. Cell. Proteom. 10, M110.005033 (2011).","journal-title":"Mol. Cell. Proteom."},{"key":"1333_CR182","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/ard.2008.096917","volume":"68","author":"I Auger","year":"2009","unstructured":"Auger, I. et al. New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA. Ann. Rheum. Dis. 68, 591\u2013594 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"1333_CR183","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.4049\/jimmunol.174.11.6599","volume":"174","author":"AJ Gross","year":"2005","unstructured":"Gross, A. J., Hochberg, D., Rand, W. M. & Thorley-Lawson, D. A. EBV and systemic lupus erythematosus: a new perspective. J. Immunol. 174, 6599\u20136607 (2005).","journal-title":"J. Immunol."},{"key":"1333_CR184","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tjog.2024.01.008","volume":"63","author":"C-J Chen","year":"2024","unstructured":"Chen, C.-J. Epstein-Barr virus reactivation and disease flare of systemic lupus erythematosus. Taiwan. J. Obstet. Gynecol. 63, 161\u2013164 (2024).","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"1333_CR185","first-page":"44","volume":"32","author":"C-J Chen","year":"2005","unstructured":"Chen, C.-J. et al. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J. Rheumatol. 32, 44\u201347 (2005).","journal-title":"J. Rheumatol."},{"key":"1333_CR186","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12969-023-00807-w","volume":"21","author":"T Zhang","year":"2023","unstructured":"Zhang, T. et al. Clinical phenotypes and prognosis of cytomegalovirus infection in the pediatric systemic lupus erythematosus: a longitudinal analysis. Pediatr. Rheumatol. 21, 25 (2023).","journal-title":"Pediatr. Rheumatol."},{"key":"1333_CR187","doi-asserted-by":"publisher","DOI":"10.1590\/1984-0462\/2022\/40\/2020291","volume":"40","author":"LCM Barros","year":"2021","unstructured":"Barros, L. C. M., Lima, M. E. S., Pereira, R. M. M., Vasconcelos, L. A. A. & Rabelo, W. C. Juvenile lupus, cytomegalovirus infection and cardiac tamponade: case report. Rev. Paul. Pediatr. 40, e2020291 (2021).","journal-title":"Rev. Paul. Pediatr."},{"key":"1333_CR188","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/0961203317711009","volume":"27","author":"WT Lin","year":"2018","unstructured":"Lin, W. T. et al. Increased risk of hepatitis B virus reactivation in systemic lupus erythematosus patients receiving immunosuppressants: a retrospective cohort study. Lupus 27, 66\u201375 (2018).","journal-title":"Lupus"},{"key":"1333_CR189","doi-asserted-by":"publisher","first-page":"9116","DOI":"10.3390\/ijms22179116","volume":"22","author":"MH Chen","year":"2021","unstructured":"Chen, M. H. et al. High risk of viral reactivation in hepatitis B patients with systemic lupus erythematosus. Int. J. Mol. Sci. 22, 9116 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1333_CR190","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/acr.22205","volume":"66","author":"K Umekita","year":"2014","unstructured":"Umekita, K. et al. Treatment with anti-tumor necrosis factor biologic agents in human t lymphotropic virus type I-positive patients with rheumatoid arthritis. Arthritis Care Res. 66, 788\u2013792 (2014).","journal-title":"Arthritis Care Res."},{"key":"1333_CR191","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/art.40461","volume":"70","author":"T Suzuki","year":"2018","unstructured":"Suzuki, T. et al. Brief report: attenuated effectiveness of tumor necrosis factor inhibitors for anti-human T lymphotropic virus type I antibody-positive rheumatoid arthritis. Arthritis Rheumatol. 70, 1014\u20131021 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"1333_CR192","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fmicb.2020.00152","volume":"11","author":"K Umekita","year":"2020","unstructured":"Umekita, K. & Okayama, A. HTLV-1 infection and rheumatic diseases. Front. Microbiol. 11, 152 (2020).","journal-title":"Front. Microbiol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01333-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01333-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01333-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T01:02:38Z","timestamp":1769648558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01333-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":192,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1333"],"URL":"https:\/\/doi.org\/10.1038\/s41584-025-01333-7","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"13 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}